{
  "DOI": "10.1038/s41431-020-00721-9",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-020-00721-9",
  "alternative-id": [
    "721"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "17 March 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "3 August 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "1 September 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "18 September 2020"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    },
    {
      "group": {
        "label": "Consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "All authors consent to the publication of the manuscript."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Stamerra",
      "given": "Cosimo Andrea",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "De Feo",
      "given": "Martina",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-7005-3218",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Castelli",
      "given": "Vanessa",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "d’Angelo",
      "given": "Michele",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cimini",
      "given": "Annamaria",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0003-1005-4689",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Grassi",
      "given": "Davide",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ferri",
      "given": "Claudio",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2020,
        9,
        18
      ]
    ],
    "date-time": "2020-09-18T11:11:05Z",
    "timestamp": 1600427465000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        9,
        17
      ]
    ],
    "date-time": "2021-09-17T23:24:38Z",
    "timestamp": 1631921078000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        16
      ]
    ],
    "date-time": "2024-03-16T19:02:24Z",
    "timestamp": 1710615744772
  },
  "is-referenced-by-count": 3,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2020,
        9,
        18
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2021,
          2
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            9,
            18
          ]
        ],
        "date-time": "2020-09-18T00:00:00Z",
        "timestamp": 1600387200000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            9,
            18
          ]
        ],
        "date-time": "2020-09-18T00:00:00Z",
        "timestamp": 1600387200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-020-00721-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-020-00721-9",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-020-00721-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "218-224",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2020,
        9,
        18
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2020,
        9,
        18
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        2
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.18632/aging.102191",
      "doi-asserted-by": "publisher",
      "key": "721_CR1",
      "unstructured": "Granzotto A, Bomba M, Castelli V, Navarra R, Massetti N, d’Aurora M, et al. Inhibition of de novo ceramide biosynthesis affects aging phenotype in an in vitro model of neuronal senescence. Aging. 2019;11. https://doi.org/10.18632/aging.102191."
    },
    {
      "DOI": "10.1172/jci.insight.99171",
      "doi-asserted-by": "publisher",
      "key": "721_CR2",
      "unstructured": "Miller JJ, Aoki K, Moehring F, Murphy C, O’Hara C, Tiemeyer M, et al. Neuropathic pain in a Fabry disease rat model. JCI Insight. 2018;3. https://doi.org/10.1172/jci.insight.99171."
    },
    {
      "DOI": "10.1016/B978-0-12-410529-4.00038-3",
      "doi-asserted-by": "crossref",
      "key": "721_CR3",
      "unstructured": "Desnick RJ. Fabry disease. In: Rosenberg’s molecular and genetic basis of neurologic and psychiatric disease. 5th Edition Elsevier; 2015. p. 419–30."
    },
    {
      "key": "721_CR4",
      "unstructured": "NCBI. https://www.ncbi.nlm.nih.gov/nuccore. 2020."
    },
    {
      "DOI": "10.1038/jhg.2012.32",
      "author": "LT Turaça",
      "doi-asserted-by": "publisher",
      "first-page": "347",
      "journal-title": "J Hum Genet",
      "key": "721_CR5",
      "unstructured": "Turaça LT, Pessoa JG, Motta FL, Müller KB, Lourenço CM, Marques WJ, et al. New mutations in the GLA gene in Brazilian families with Fabry disease. J Hum Genet. 2012;57:347–51.",
      "volume": "57",
      "year": "2012"
    },
    {
      "DOI": "10.1212/WNL.50.6.1746",
      "author": "KE Crutchfield",
      "doi-asserted-by": "publisher",
      "first-page": "1746",
      "journal-title": "Neurology",
      "key": "721_CR6",
      "unstructured": "Crutchfield KE, Patronas NJ, Dambrosia JM, Frei KP, Banerjee TK, Barton NW, et al. Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology. 1998;50:1746–9.",
      "volume": "50",
      "year": "1998"
    },
    {
      "DOI": "10.1097/01.gim.0000237866.70357.c6",
      "author": "CM Eng",
      "doi-asserted-by": "publisher",
      "first-page": "539",
      "journal-title": "Genet Med",
      "key": "721_CR7",
      "unstructured": "Eng CM, Germain DP, Banikazemi M, Warnock DG, Wanner C, Hopkin RJ, et al. Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med. 2006;8:539–48.",
      "volume": "8",
      "year": "2006"
    },
    {
      "DOI": "10.1016/S0149-2918(07)80115-9",
      "author": "C Wanner",
      "doi-asserted-by": "publisher",
      "first-page": "S2",
      "issue": "Suppl A",
      "journal-title": "Clin Ther",
      "key": "721_CR8",
      "unstructured": "Wanner C. Fabry disease model: a rational approach to the management of Fabry disease. Clin Ther. 2007;29 Suppl A:S2–5.",
      "volume": "29",
      "year": "2007"
    },
    {
      "DOI": "10.1161/01.STR.32.7.1559",
      "author": "G Altarescu",
      "doi-asserted-by": "publisher",
      "first-page": "1559",
      "journal-title": "Stroke",
      "key": "721_CR9",
      "unstructured": "Altarescu G, Moore DF, Pursley R, Campia U, Goldstein S, Bryant M, et al. Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke. 2001;32:1559–62.",
      "volume": "32",
      "year": "2001"
    },
    {
      "DOI": "10.1002/1531-8249(200002)47:2\u003c229::AID-ANA13\u003e3.0.CO;2-T",
      "author": "T DeGraba",
      "doi-asserted-by": "publisher",
      "first-page": "229",
      "journal-title": "Ann Neurol",
      "key": "721_CR10",
      "unstructured": "DeGraba T, Azhar S, Dignat-George F, Brown E, Boutière B, Altarescu G, et al. Profile of endothelial and leukocyte activation in Fabry patients. Ann Neurol. 2000;47:229–33.",
      "volume": "47",
      "year": "2000"
    },
    {
      "DOI": "10.1111/j.1447-0756.1985.tb00045.x",
      "author": "O Tsutsumi",
      "doi-asserted-by": "publisher",
      "first-page": "39",
      "journal-title": "Asia Ocean J Obstet Gynaecol",
      "key": "721_CR11",
      "unstructured": "Tsutsumi O, Sato M, Sato K, Sato K, Mizuno M, Sakamoto S. Early prenatal diagnosis of inborn error of metabolism: a case report of a fetus affected with Fabry’s disease. Asia Ocean J Obstet Gynaecol. 1985;11:39–45.",
      "volume": "11",
      "year": "1985"
    },
    {
      "DOI": "10.1007/s10545-006-0196-0",
      "author": "AC Vedder",
      "doi-asserted-by": "publisher",
      "first-page": "106",
      "journal-title": "J Inherit Metab Dis",
      "key": "721_CR12",
      "unstructured": "Vedder AC, Strijland A, vd Bergh Weerman MA, Florquin S, Aerts JMFG, Hollak CEM. Manifestations of Fabry disease in placental tissue. J Inherit Metab Dis. 2006;29:106–11.",
      "volume": "29",
      "year": "2006"
    },
    {
      "DOI": "10.1016/B978-1-4160-0252-9.50017-3",
      "doi-asserted-by": "crossref",
      "key": "721_CR13",
      "unstructured": "Shayman JA, Killen PD. Fabry disease. In: Molecular and genetic basis of renal disease. Philadelphia Saunders: Elsevier; 2008. p. 195–9."
    },
    {
      "DOI": "10.1016/j.amjhyper.2006.01.011",
      "author": "J Kleinert",
      "doi-asserted-by": "publisher",
      "first-page": "782",
      "journal-title": "Am J Hypertens",
      "key": "721_CR14",
      "unstructured": "Kleinert J, Dehout F, Schwarting A, de Lorenzo AG, Ricci R, Kampmann C, et al. Prevalence of uncontrolled hypertension in patients with Fabry disease. Am J Hypertens. 2006;19:782–7.",
      "volume": "19",
      "year": "2006"
    },
    {
      "DOI": "10.1161/ATVBAHA.113.302200",
      "author": "S Choi",
      "doi-asserted-by": "publisher",
      "first-page": "81",
      "journal-title": "Arterioscler Thromb Vasc Biol",
      "key": "721_CR15",
      "unstructured": "Choi S, Kim JA, Na H-Y, de Lorenzo AG, Ricci R, Kampmann C, et al. Globotriaosylceramide induces lysosomal degradation of endothelial K Ca 3.1 in Fabry disease. Arterioscler Thromb Vasc Biol. 2014;34:81–89.",
      "volume": "34",
      "year": "2014"
    },
    {
      "DOI": "10.1161/ATVBAHA.113.302744",
      "author": "K Satoh",
      "doi-asserted-by": "publisher",
      "first-page": "2",
      "journal-title": "Arterioscler Thromb Vasc Biol",
      "key": "721_CR16",
      "unstructured": "Satoh K. Globotriaosylceramide induces endothelial dysfunction in fabry disease. Arterioscler Thromb Vasc Biol. 2014;34:2–4.",
      "volume": "34",
      "year": "2014"
    },
    {
      "DOI": "10.1007/8904_2012_177",
      "author": "A Pisani",
      "doi-asserted-by": "publisher",
      "first-page": "41",
      "journal-title": "JIMD Rep",
      "key": "721_CR17",
      "unstructured": "Pisani A, Spinelli L, Visciano B, Capuano I, Sabbatini M, Riccio E, et al. Effects of switching from agalsidase Beta to agalsidase alfa in 10 patients with anderson-fabry disease. JIMD Rep. 2013;9:41–8.",
      "volume": "9",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.bbadis.2010.05.003",
      "author": "SM Rombach",
      "doi-asserted-by": "publisher",
      "first-page": "741",
      "journal-title": "Biochim Biophys Acta",
      "key": "721_CR18",
      "unstructured": "Rombach SM, Dekker N, Bouwman MG, Linthorst GE, Zwinderman AH, Wijburg FA, et al. Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease. Biochim Biophys Acta. 2010;1802:741–8.",
      "volume": "1802",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.ymgmr.2019.100454",
      "author": "DP Germain",
      "doi-asserted-by": "publisher",
      "first-page": "100454",
      "journal-title": "Mol Genet Metab Rep",
      "key": "721_CR19",
      "unstructured": "Germain DP, Elliott PM, Falissard B, Fomin V, Hilz MJ, Jovanovic A, et al. The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: a systematic literature review by a European panel of experts. Mol Genet Metab Rep. 2019;19:100454.",
      "volume": "19",
      "year": "2019"
    },
    {
      "DOI": "10.1161/01.CIR.99.18.2434",
      "author": "J Blacher",
      "doi-asserted-by": "publisher",
      "first-page": "2434",
      "journal-title": "Circulation",
      "key": "721_CR20",
      "unstructured": "Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation. 1999;99:2434–9.",
      "volume": "99",
      "year": "1999"
    },
    {
      "DOI": "10.1007/s10545-011-9428-z",
      "author": "K Nicholls",
      "doi-asserted-by": "publisher",
      "first-page": "885",
      "journal-title": "J Inherit Metab Dis",
      "key": "721_CR21",
      "unstructured": "Nicholls K. Increased arterial stiffness is associated with high cardiovascular mortality in male Fabry patients. J Inherit Metab Dis. 2012;35:885–9.",
      "volume": "35",
      "year": "2012"
    },
    {
      "DOI": "10.1161/HYP.0000000000000033",
      "author": "RR Townsend",
      "doi-asserted-by": "publisher",
      "first-page": "698",
      "journal-title": "Hypertension",
      "key": "721_CR22",
      "unstructured": "Townsend RR, Wilkinson IB, Schiffrin EL, Avolio AP, Chirinos JA, Cockcroft JR, et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension. 2015;66:698–722.",
      "volume": "66",
      "year": "2015"
    },
    {
      "DOI": "10.1136/jmedgenet-2014-102797",
      "author": "DP Germain",
      "doi-asserted-by": "publisher",
      "first-page": "353",
      "journal-title": "J Med Genet",
      "key": "721_CR23",
      "unstructured": "Germain DP, Charrow J, Desnick RJ, Guffon N, Kempf J, Lachmann RH, et al. Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease. J Med Genet. 2015;52:353–8.",
      "volume": "52",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10545-015-9845-5",
      "author": "R Schiffmann",
      "doi-asserted-by": "publisher",
      "first-page": "1129",
      "journal-title": "J Inherit Metab Dis",
      "key": "721_CR24",
      "unstructured": "Schiffmann R, Swift C, Wang X, Blankenship D, Ries M. A prospective 10-year study of individualized, intensified enzyme replacement therapy in advanced Fabry disease. J Inherit Metab Dis. 2015;38:1129–36.",
      "volume": "38",
      "year": "2015"
    },
    {
      "DOI": "10.1007/BF03401671",
      "author": "CM Eng",
      "doi-asserted-by": "publisher",
      "first-page": "174",
      "journal-title": "Mol Med",
      "key": "721_CR25",
      "unstructured": "Eng CM, Ashley GA, Burgert TS, Enriquez AL, D’Souza M, Desnick RJ. Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes. Mol Med. 1997;3:174–82.",
      "volume": "3",
      "year": "1997"
    },
    {
      "DOI": "10.1136/jmedgenet-2014-102872",
      "author": "BE Smid",
      "doi-asserted-by": "publisher",
      "first-page": "262",
      "journal-title": "J Med Genet",
      "key": "721_CR26",
      "unstructured": "Smid BE, van der Tol L, Biegstraaten M, Linthorst GE, Hollak CEM, Poorthuis BJHM. Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease. J Med Genet. 2015;52:262–8.",
      "volume": "52",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pone.0173358",
      "author": "R El Dib",
      "doi-asserted-by": "publisher",
      "first-page": "e0173358",
      "journal-title": "PLoS One",
      "key": "721_CR27",
      "unstructured": "El Dib R, Gomaa H, Ortiz A, Politei J, Kapoor A, Barreto F. Enzyme replacement therapy for Anderson-Fabry disease: a complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studies. PLoS One. 2017;12:e0173358.",
      "volume": "12",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.anorl.2019.04.014",
      "author": "C Eyermann",
      "doi-asserted-by": "publisher",
      "first-page": "273",
      "journal-title": "Eur Ann Otorhinolaryngol Head Neck Dis",
      "key": "721_CR28",
      "unstructured": "Eyermann C, Raguin T, Rohmer D, Noel E, Charpiot A. Cochleovestibular manifestations in Fabry disease: Importance of screening and systematic ENT evaluation. Eur Ann Otorhinolaryngol Head Neck Dis. 2019;136:273–9.",
      "volume": "136",
      "year": "2019"
    },
    {
      "key": "721_CR29",
      "unstructured": "Schiffmann R, Moore DF. Neurological effects of enzyme replacement therapy in Fabry disease. In: Mehta A, Beck M, Sunder-Plassmann G, editors. Fabry disease: perspectives from 5 years of FOS. Oxford PharmaGenesis: Oxford; 2006. http://www.ncbi.nlm.nih.gov/books/NBK11595/. Accessed 14 Jan 2020."
    },
    {
      "DOI": "10.1056/NEJM200107053450102",
      "author": "CM Eng",
      "doi-asserted-by": "publisher",
      "first-page": "9",
      "journal-title": "N Engl J Med",
      "key": "721_CR30",
      "unstructured": "Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, et al. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry’s disease. N Engl J Med. 2001;345:9–16.",
      "volume": "345",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S0021-9150(03)00097-2",
      "author": "S Blankenberg",
      "doi-asserted-by": "publisher",
      "first-page": "191",
      "journal-title": "Atherosclerosis",
      "key": "721_CR31",
      "unstructured": "Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis. 2003;170:191–203.",
      "volume": "170",
      "year": "2003"
    },
    {
      "DOI": "10.1681/ASN.2007030312",
      "author": "DG Warnock",
      "doi-asserted-by": "publisher",
      "first-page": "1368",
      "journal-title": "J Am Soc Nephrol",
      "key": "721_CR32",
      "unstructured": "Warnock DG. Enzyme replacement therapy and Fabry kidney disease: quo vadis? J Am Soc Nephrol. 2007;18:1368–70.",
      "volume": "18",
      "year": "2007"
    },
    {
      "DOI": "10.1161/HYPERTENSIONAHA.112.195685",
      "author": "SM Rombach",
      "doi-asserted-by": "publisher",
      "first-page": "998",
      "journal-title": "Hypertension",
      "key": "721_CR33",
      "unstructured": "Rombach SM, van den Bogaard B, de Groot E, Groener JEM, Poorthuis BJ, Linthorst GE, et al. Vascular aspects of Fabry disease in relation to clinical manifestations and elevations in plasma globotriaosylsphingosine. Hypertension. 2012;60:998–1005.",
      "volume": "60",
      "year": "2012"
    },
    {
      "DOI": "10.1186/1471-2369-15-72",
      "author": "S Waldek",
      "doi-asserted-by": "publisher",
      "first-page": "72",
      "journal-title": "BMC Nephrol",
      "key": "721_CR34",
      "unstructured": "Waldek S, Feriozzi S. Fabry nephropathy: a review—how can we optimize the management of Fabry nephropathy? BMC Nephrol. 2014;15:72.",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1111/ijcp.12914",
      "author": "R Reisin",
      "doi-asserted-by": "publisher",
      "first-page": "e12914",
      "journal-title": "Int J Clin Pr",
      "key": "721_CR35",
      "unstructured": "Reisin R, Perrin A, García-Pavía P. Time delays in the diagnosis and treatment of Fabry disease. Int J Clin Pr. 2017;71:e12914.",
      "volume": "71",
      "year": "2017"
    }
  ],
  "reference-count": 35,
  "references-count": 35,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-020-00721-9"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Effects of agalsidase-β administration on vascular function and blood pressure in familial Anderson–Fabry disease"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "29"
}